|
|
|
01.06.26 - 16:33
|
Moderna Snags $50 Million Ebola Vax Contract (ZeroHedge)
|
|
|
Moderna Snags $50 Million Ebola Vax Contract
Moderna is receiving up to $50 million to accelerate the development of an Ebola vaccine, as the virus continues to spread in the eastern Democratic Republic of Congo.
The funding is coming from global health organization CEPI, which told Reuters that it was possible to bring the vaccines to trial phase within a couple of months.
CEPI said it would also invest up to $8.6 million for a shot developed by the University of Oxford and manufactured by the Serum Institute of India, and an initial $3.2 million for a vaccine developed by the International AIDS Vaccine Initiative. -Reuters
"Every day counts in the race against this deadly disease," said Richard Hatchett, head of CEPI, adding that the vaccines are on "a not infinitely distant horizon."
That said, Hatchett also cautioned that vaccine development can be unpredictable, plus there's a 'challenging security situation' in eastern Congo that might make trials complex -...
|
|
|
|
|
01.06.26 - 13:31
|
Moderna entwickelt Impfstoff gegen Ebola (Börsen-Zeitung)
|
|
|
Moderna entwickelt einen Impfstoff gegen das Bundibugyo-Ebolavirus. Grund ist der Ausbruch im Osten des Kongo mit hunderten Verdachts- und Todesfällen. Millionen fließen in die Entwicklung und klinische Tests....
|
|
|
|
|
|
|
|
|
|
|
23.05.26 - 15:30
|
Fraudster trying to sell fake ancient statues to Sotheby′s foiled over bogus invoices (The Guardian)
|
|
|
Paperwork supplied by Andrew Crowley, 46, found to be made using printing methods 25 years too modernA fraudster who tried to sell fake ancient statues to Sotheby's was foiled when his bogus accompanying paperwork was found to be written with printing methods that were 25 years too modern, a court has heard.Andrew Crowley, 46, asked the auctioneers to value three Cycladic figures and one Anatolian stargazer statuette that he had inherited from his grandfather, Southwark crown court in London was told on Friday. Continue reading......
|
|
|
|
|
|
|
|
|
|
|
|
|
21.05.26 - 15:42
|
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now (24/7 Wall St.)
|
|
|
Moderna (NASDAQ:MRNA) is back in the headlines after ripping 63.17% higher year to date on a surprise Q1 revenue triple and renewed pipeline excitement. But the underlying story deserves a closer look. The Moderna Story Has Not Changed Strip away the bounce and the fundamentals tell the same story long-term investors have heard for three ... Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now...
|
|
|
|
|
|
|
|
|
|
|
|
|
13.05.26 - 10:13
|
Moderna: Vor dem großen Ausbruch (Der Aktionaer)
|
|
|
Nach dem heftigen Corona-Boom-Absturz läuft die Moderna-Aktie wieder heiß. Neue Fantasie liefert die Forschung an Impfstoffen zum Schutz vor Hantaviren. Der AKTIONÄR nimmt die Aktie neu ins Depot auf und setzt auf das enorme Comeback-Potenzial....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
